These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 3471320
21. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. Periyasamy S, Sun L, Gentry LE, Brattain MG. J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926 [Abstract] [Full Text] [Related]
22. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Franzén P, Ichijo H, Miyazono K. Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495 [Abstract] [Full Text] [Related]
23. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Manning AM, Williams AC, Game SM, Paraskeva C. Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718 [Abstract] [Full Text] [Related]
24. Further studies of the role of transforming growth factor-beta in human B cell function. Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS. J Immunol; 1989 Sep 15; 143(6):1868-74. PubMed ID: 2550546 [Abstract] [Full Text] [Related]
25. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Korc M, Haussler CA, Trookman NS. Cancer Res; 1987 Sep 15; 47(18):4909-14. PubMed ID: 3497713 [Abstract] [Full Text] [Related]
26. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Hsu S, Huang F, Hafez M, Winawer S, Friedman E. Cell Growth Differ; 1994 Mar 15; 5(3):267-75. PubMed ID: 8018559 [Abstract] [Full Text] [Related]
27. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line. Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG. Cancer Lett; 1988 Jun 15; 40(2):219-32. PubMed ID: 3164250 [Abstract] [Full Text] [Related]
28. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK. Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532 [Abstract] [Full Text] [Related]
29. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta. Wollenberg GK, Semple E, Quinn BA, Hayes MA. Cancer Res; 1987 Dec 15; 47(24 Pt 1):6595-9. PubMed ID: 3499977 [Abstract] [Full Text] [Related]
30. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. Allen RE, Boxhorn LK. J Cell Physiol; 1987 Dec 15; 133(3):567-72. PubMed ID: 3480289 [Abstract] [Full Text] [Related]
31. Colon absorptive epithelial cells lose proliferative response to TGF alpha as they differentiate. Huang F, Sauma S, Yan Z, Friedman E. Exp Cell Res; 1995 Jul 15; 219(1):8-14. PubMed ID: 7628553 [Abstract] [Full Text] [Related]
32. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F, Newman E, Theodorescu D, Kerbel RS, Friedman E. Cell Growth Differ; 1995 Dec 15; 6(12):1635-42. PubMed ID: 9019169 [Abstract] [Full Text] [Related]
33. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ. Cancer Res; 1995 Jun 01; 55(11):2380-6. PubMed ID: 7757990 [Abstract] [Full Text] [Related]
34. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R. J Cell Physiol; 1987 Mar 01; 130(3):397-409. PubMed ID: 3494020 [Abstract] [Full Text] [Related]
35. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Lynch MJ, Pelosi L, Carboni JM, Merwin J, Coleman K, Wang RC, Lin PF, Henry DL, Brattain MG. Cancer Res; 1993 Sep 01; 53(17):4041-7. PubMed ID: 8358733 [Abstract] [Full Text] [Related]
36. Bi-functional action of transforming growth factor-beta on DNA synthesis in early passage human fetal fibroblasts. Hill DJ, Strain AJ, Elstow SF, Swenne I, Milner RD. J Cell Physiol; 1986 Aug 01; 128(2):322-8. PubMed ID: 3488321 [Abstract] [Full Text] [Related]
37. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line. Levine AE, Lewis LR. Cancer Lett; 1993 Jan 15; 68(1):33-41. PubMed ID: 8422647 [Abstract] [Full Text] [Related]
38. Appearance of high affinity receptors for type beta transforming growth factor during differentiation of murine embryonal carcinoma cells. Rizzino A. Cancer Res; 1987 Aug 15; 47(16):4386-90. PubMed ID: 2886219 [Abstract] [Full Text] [Related]